O'Brien Kate, Daffern Michael
School of Psychology and Psychiatry, Monash University, Melbourne, Victoria, Australia.
Centre for Forensic Behavioural Science, Swinburne University of Technology, Hawthorn, Victoria, Australia.
Psychiatr Psychol Law. 2016 Oct 13;24(2):259-277. doi: 10.1080/13218719.2016.1230923. eCollection 2017.
This retrospective archival study examines whether pre-treatment responsivity characteristics influence access to, engagement in, and completion of a violent offender treatment programme. The participants are 115 violent offenders referred for a group-based multi-module treatment programme in medium- and high-security correctional facilities in Victoria, Australia. The case files for each participant were reviewed and information regarding responsivity factors and responses to treatment were gathered. Responsivity characteristics include psychopathy (Psychopathy Checklist: Screening Version; PCL:SV), denial and minimisation (Denial and Minimisation Checklist - Third Edition; DMCL-III), and measures of motivation to engage in treatment and guilt and shame associated with violent offending. Engagement was scored using the Response to Treatment Scale. Offenders with higher PCL:SV Factor 2 scores were less likely to be offered a place in the programme and offenders with greater external pressure or motivation to participate in treatment were more likely to commence treatment. Psychopathy and pre-treatment denial and minimisation of offending are related to poorer engagement in treatment; feelings of guilt and shame, along with motivation to participate in treatment, are positively associated with engagement. Predictors of treatment completion include external motivators promoting participation in treatment, within-treatment behaviours (e.g. inappropriate or disruptive behaviour), and psychopathy.
这项回顾性档案研究考察了治疗前的反应性特征是否会影响暴力罪犯治疗项目的参与机会、参与程度和完成情况。研究对象是115名被转介到澳大利亚维多利亚州中高安全级别的惩教设施中参加一个基于小组的多模块治疗项目的暴力罪犯。查阅了每位参与者的病例档案,并收集了有关反应性因素和治疗反应的信息。反应性特征包括精神病态(《精神病态检查表:筛查版》;PCL:SV)、否认和淡化(《否认和淡化检查表 - 第三版》;DMCL-III),以及参与治疗的动机和与暴力犯罪相关的内疚和羞耻感的测量指标。使用《治疗反应量表》对参与程度进行评分。PCL:SV因子2得分较高的罪犯获得该项目名额的可能性较小,而外部压力较大或参与治疗动机较强的罪犯开始治疗的可能性较大。精神病态以及治疗前对犯罪的否认和淡化与较差的治疗参与度有关;内疚和羞耻感以及参与治疗的动机与参与度呈正相关。治疗完成的预测因素包括促进参与治疗的外部动机、治疗期间的行为(如不当或破坏性行为)以及精神病态。